|
|
 |
|
Viewing report
|
|
|
|
The Drug Delivery Outlook 2001
Business Insights, July 2001
In an environment where there is constant pressure to launch new products onto the market, the cost of investment in drug delivery compares very favourably with new drug discovery. Subsequently, the market for drug delivery systems (DDS) is growing faster than the pharmaceutical market overall. Another major opportunity for DDS is the flood of blockbusters due to lose patent protection within the next 10 years as product differentiation can significantly prolong a product''s life. The Drug Delivery Outlook 2001 examines the role of drug delivery systems as an element in product lifecycle management, highlighting its potential for aiding product differentiation, both in mainstream pharma and the generic sector.
Customers who bought this item also bought
Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices
Cardiovascular Drug Delivery - Technologies, Markets and Companies
Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
Growth Strategies for Supergenerics Organizations - Opportunities in Addressing Unmet Medical Needs and Providing Cost-Effective Solutions for Product Development in Emerging Markets
Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition
Chinese Markets for Drug Delivery System
Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators
Nanoparticle Drug Delivery Market Report
Drug Delivery in Cancer - Technologies, Markets and Companies
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
|
|
|
|
